Table 3.
Distribution of antiglaucomatous medication number
Active principle number | Patients, n (%) | Total (%) |
---|---|---|
One active principle | 74 (47.7) | 74 (47.7) |
Fixed combination | 35 (22.6) | 44 (28.4) |
2 separate active principles | 9 (5.8) | |
Fixed combination + one active principle | 25 (16.1) | 30 (19.4) |
3 separate active principles | 5 (3.3) | |
Fixed combination + 2 separate active principles | 6 (3.9) | 7 (4.5) |
4 separate active principles | 1 (0.6) | |
Total | 155 | 155 |